| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 478.456 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 587.198 | 93 |
| GSM780709 | Untreated after 4 days (C3_1) | 614.852 | 93 |
| GSM780719 | Untreated after 4 days (C1_2) | 488.191 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 550.139 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 584.304 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 437.335 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 620.868 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 518.593 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 447.509 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 579.149 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 511.205 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 873.142 | 95 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 667.002 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 900.377 | 95 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 839.788 | 95 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 724.841 | 94 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 917.447 | 95 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 224.265 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 341.743 | 89 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 454.151 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 213.763 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 371.809 | 89 |